Nautilus Biotechnology, Inc.
NAUT
$0.701
$0.03284.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.69M | -68.66M | -70.78M | -70.21M | -69.64M |
| Total Depreciation and Amortization | 6.42M | 6.39M | 6.35M | 6.39M | 6.26M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.70M | 10.01M | 10.74M | 9.86M | 9.87M |
| Change in Net Operating Assets | -4.14M | -4.55M | -5.46M | -4.77M | -3.85M |
| Cash from Operations | -54.71M | -56.82M | -59.15M | -58.74M | -57.36M |
| Capital Expenditure | -2.34M | -2.45M | -2.88M | -2.28M | -2.45M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.93M | 65.86M | 69.13M | -9.64M | 11.11M |
| Cash from Investing | 63.59M | 63.41M | 66.25M | -11.92M | 8.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 693.00K | 917.00K | 1.14M | 957.00K | 833.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 693.00K | 917.00K | 1.14M | 957.00K | 833.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.57M | 7.51M | 8.25M | -69.70M | -47.87M |